John A Treffalls

Dr. John A Treffalls

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
QYQi Yan
Qi Yan
SPSanaa Prasla
Sanaa Prasla
DCDaniel C. Carlisle
Daniel C. Carlisle
ARAashish Rajesh
Aashish Rajesh
John A TreffallsJohn A Treffalls
John A Treffalls
MDMark G Davies
Mark G Davies

8 July 2023 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
John A TreffallsJohn A Treffalls
John A Treffalls
ASAakash M. Shah
Aakash M. Shah
CWChristopher M. Worrell
Christopher M. Worrell
RTRebecca N. Treffalls
Rebecca N. Treffalls
NDNitin A. Das
Nitin A. Das
JCJohn H. Calhoon
John H. Calhoon

11 July 2022 in JTCVS Open
Verified
Journal Article
Open access
John A TreffallsJohn A Treffalls
John A Treffalls
CSChristopher B. Sylvester
Christopher B. Sylvester
UPUmang Parikh
Umang Parikh
RZRodrigo Zea-Vera
Rodrigo Zea-Vera
CRChristopher T. Ryan
Christopher T. Ryan
RGRavi K. Ghanta
Ravi K. Ghanta
We examined readmissions and resource use during the first postoperative year in patients who underwent thoracic endovascular aortic repair or open surgical repair of Stanford type B aortic dissection. The Nationwide Readmissions Database (2016-2018) was queried for patients with type B aortic dissection who underwent thoracic endovascular aortic repair or open surgical repair. The primary outcome was readmission during the first postoperative year. Secondary outcomes included 30-day and 90-day readmission rates, in-hospital mortality, length of stay, and cost. A Cox proportional hazards model was used to determine risk factors for readmission. During the study period, type B aortic dissection repair was performed in 6456 patients, of whom 3517 (54.5%) underwent thoracic endovascular aortic repair and 2939 (45.5%) underwent open surgical repair. Patients undergoing thoracic endovascular aortic repair were older (63 vs 59 years; P < .001) with fewer comorbidities (Elixhauser score of 11 vs 17; P < .001) than patients undergoing open surgical repair. Thoracic endovascular aortic repair was performed electively more often than open surgical repair (29% vs 20%; P < .001). In-hospital mortality was 9% overall and lower in the thoracic endovascular aortic repair cohort than in the open surgical repair cohort (5% vs 13%; P < .001). However, the 90-day readmission rate was comparable between the thoracic endovascular aortic repair and open surgical repair cohorts (28% vs 27%; P = .7). Freedom from readmission for up to 1 year was also similar between cohorts (P = .6). Independent predictors of 1-year readmission included length of stay more than 10 days (P = .005) and Elixhauser comorbidity risk index greater than 4 (P = .033). Approximately one-third of all patients with type B aortic dissection were readmitted within 90 days after aortic intervention. Surprisingly, readmission during the first postoperative year was similar in the open surgical repair and thoracic endovascular aortic repair cohorts, despite marked differences in preoperative patient characteristics and interventions.

22 April 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
RTRebecca N. Treffalls
Rebecca N. Treffalls
QYQi Yan
Qi Yan
John A TreffallsJohn A Treffalls
John A Treffalls
WCWesley T. Clothier
Wesley T. Clothier
MDMark G Davies
Mark G Davies

5 January 2022 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
John A TreffallsJohn A Treffalls
John A Treffalls
RTRebecca N. Treffalls
Rebecca N. Treffalls
HZHarbin Zachary
Harbin Zachary
WCWesley Clothier
Wesley Clothier
PTPreston Harris Tolbert
Preston Harris Tolbert
MDMark G Davies
Mark G Davies

22 July 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
PBParnia Behinaein
Parnia Behinaein
John A TreffallsJohn A Treffalls
John A Treffalls
HHHollis Hutchings
Hollis Hutchings
Ikenna OkerekeIkenna Okereke
Ikenna Okereke
Lung cancer is the most common cancer killer in the world. The standard of care for surgical treatment of non-small cell lung cancer has been lobectomy. Recent studies have identified that sublobar resection has non-inferior survival rates compared to lobectomy, however. Sublobar resection may increase the number of patients who can tolerate surgery and reduce postoperative pulmonary decline. Sublobar resection appears to have equivalent results to surgery in patients with small, peripheral tumors and no lymph node disease. As the utilization of segmentectomy increases, there may be some centers that perform this operation more than other centers. Care must be taken to ensure that all patients have access to this modality. Future investigations should focus on examining the outcomes from segmentectomy as it is applied more widely. When employed on a broad scale, morbidity and survival rates should be monitored. As segmentectomy is performed more frequently, patients may experience improved postoperative quality of life while maintaining the same oncologic benefit.